280 related articles for article (PubMed ID: 30272366)
21. High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma.
Liu Y; Yang L; An H; Chang Y; Zhang W; Zhu Y; Xu L; Xu J
Sci Rep; 2015 Nov; 5():16954. PubMed ID: 26599282
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical analysis of phosphorylated mammalian target of rapamycin and its downstream signaling components in invasive breast cancer.
Ma BL; Shan MH; Sun G; Ren GH; Dong C; Yao X; Zhou M
Mol Med Rep; 2015 Oct; 12(4):5246-54. PubMed ID: 26151180
[TBL] [Abstract][Full Text] [Related]
23. PSMB4 expression associates with epithelial ovarian cancer growth and poor prognosis.
Liu R; Lu S; Deng Y; Yang S; He S; Cai J; Qiang F; Chen C; Zhang W; Zhao S; Qian L; Mao G; Wang Y
Arch Gynecol Obstet; 2016 Jun; 293(6):1297-307. PubMed ID: 26439929
[TBL] [Abstract][Full Text] [Related]
24. CD105/Ki67 coexpression correlates with tumor progression and poor prognosis in epithelial ovarian cancer.
Liu P; Sun YL; Du J; Hou XS; Meng H
Int J Gynecol Cancer; 2012 May; 22(4):586-92. PubMed ID: 22266931
[TBL] [Abstract][Full Text] [Related]
25. Decreased semaphorin 3A expression is associated with a poor prognosis in patients with epithelial ovarian carcinoma.
Jiang H; Qi L; Wang F; Sun Z; Huang Z; Xi Q
Int J Mol Med; 2015 May; 35(5):1374-80. PubMed ID: 25812535
[TBL] [Abstract][Full Text] [Related]
26. Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell Carcinoma.
Nikkuni O; Kaira K; Toyoda M; Shino M; Sakakura K; Takahashi K; Tominaga H; Oriuchi N; Suzuki M; Iijima M; Asao T; Nishiyama M; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
Pathol Oncol Res; 2015 Sep; 21(4):1175-81. PubMed ID: 26024742
[TBL] [Abstract][Full Text] [Related]
27. [Expression of lnc-MyD88 and its relationship with the prognosis of patients with epithelial ovarian cancer].
Zhu Y; Huang JM; Zhang GN; Li JM; Huang J
Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):117-124. PubMed ID: 35184472
[No Abstract] [Full Text] [Related]
28. The role of Cyclin G1 in cellular proliferation and apoptosis of human epithelial ovarian cancer.
Jiang L; Liu R; Wang Y; Li C; Xi Q; Zhong J; Liu J; Yang S; Wang J; Huang M; Tang C; Fang Z
J Mol Histol; 2015 Jun; 46(3):291-302. PubMed ID: 25981880
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of centromere protein-A expression in patients with epithelial ovarian cancer.
Qiu JJ; Guo JJ; Lv TJ; Jin HY; Ding JX; Feng WW; Zhang Y; Hua KQ
Tumour Biol; 2013 Oct; 34(5):2971-5. PubMed ID: 23712606
[TBL] [Abstract][Full Text] [Related]
30. PFTK1 regulates cell proliferation, migration and invasion in epithelial ovarian cancer.
Zhang W; Liu R; Tang C; Xi Q; Lu S; Chen W; Zhu L; Cheng J; Chen Y; Wang W; Zhong J; Deng Y
Int J Biol Macromol; 2016 Apr; 85():405-16. PubMed ID: 26772918
[TBL] [Abstract][Full Text] [Related]
31. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.
van Geldermalsen M; Wang Q; Nagarajah R; Marshall AD; Thoeng A; Gao D; Ritchie W; Feng Y; Bailey CG; Deng N; Harvey K; Beith JM; Selinger CI; O'Toole SA; Rasko JE; Holst J
Oncogene; 2016 Jun; 35(24):3201-8. PubMed ID: 26455325
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of neuropilin 1 is associated with epithelial ovarian carcinoma.
Jiang H; Xi Q; Wang F; Sun Z; Huang Z; Qi L
Mol Med Rep; 2015 Aug; 12(2):2114-20. PubMed ID: 25845525
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of c-Abl predicts unfavorable outcome in epithelial ovarian cancer.
Zhou S; Tang L; Wang H; Dai J; Zhang J; Shen L; Ng SW; Berkowitz RS
Gynecol Oncol; 2013 Oct; 131(1):69-76. PubMed ID: 23820113
[TBL] [Abstract][Full Text] [Related]
34. ZYG11A Is Expressed in Epithelial Ovarian Cancer and Correlates With Low Grade Disease.
Achlaug L; Somri-Gannam L; Meisel-Sharon S; Sarfstein R; Dixit M; Yakar S; Hallak M; Laron Z; Werner H; Bruchim I
Front Endocrinol (Lausanne); 2021; 12():688104. PubMed ID: 34220714
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of lncRNA ASMTL-AS1 in Epithelial Ovarian Cancer Correlates with Worse Prognosis and Cancer Progression.
Xu H; Tang Y; Liu L; Yan J; Qin L
Horm Metab Res; 2022 Jul; 54(7):481-488. PubMed ID: 35835145
[TBL] [Abstract][Full Text] [Related]
36. Anti-tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS-mutated human colorectal cancer cells.
Hara Y; Minami Y; Yoshimoto S; Hayashi N; Yamasaki A; Ueda S; Masuko K; Masuko T
Cancer Med; 2020 Jan; 9(1):302-312. PubMed ID: 31709772
[TBL] [Abstract][Full Text] [Related]
37. Lobetyolin inhibits the proliferation of breast cancer cells
Chen Y; Tian Y; Jin G; Cui Z; Guo W; Zhang X; Liu X
Hum Exp Toxicol; 2021 Dec; 40(12):2074-2086. PubMed ID: 34075790
[TBL] [Abstract][Full Text] [Related]
38. Expression of phosphorylated Akt and hTERT is associated with prognosis of epithelial ovarian carcinoma.
Lee YK; Chung HH; Kim JW; Song YS; Park NH
Int J Clin Exp Pathol; 2015; 8(11):14971-6. PubMed ID: 26823830
[TBL] [Abstract][Full Text] [Related]
39. NDRG2 ablation reprograms metastatic cancer cells towards glutamine dependence
Ding M; Bu X; Li Z; Xu H; Feng L; Hu J; Wei X; Gao J; Tao Y; Cai B; Liu Y; Qu X; Shen L
Int J Biol Sci; 2020; 16(16):3100-3115. PubMed ID: 33162818
[No Abstract] [Full Text] [Related]
40. URG4 upregulation is associated with tumor growth and poor survival in epithelial ovarian cancer.
Li W; Zhou N
Arch Gynecol Obstet; 2012 Jul; 286(1):209-15. PubMed ID: 22395861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
